Publication Information

{'id': 'https://openalex.org/W4301456853', 'doi': None, 'title': 'ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation.', 'display_name': 'ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation.', 'publication_year': 2016, 'publication_date': '2016-10-01', 'ids': {'openalex': 'https://openalex.org/W4301456853', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30645821'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30645821', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.465314, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11628', 'display_name': 'Myeloproliferative Neoplasms: Diagnosis and Treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11628', 'display_name': 'Myeloproliferative Neoplasms: Diagnosis and Treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9971, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ruxolitinib', 'display_name': 'Ruxolitinib', 'score': 0.9742965}, {'id': 'https://openalex.org/keywords/polycythaemia', 'display_name': 'Polycythaemia', 'score': 0.9120972}, {'id': 'https://openalex.org/keywords/hydroxycarbamide', 'display_name': 'Hydroxycarbamide', 'score': 0.83519864}, {'id': 'https://openalex.org/keywords/phlebotomy', 'display_name': 'Phlebotomy', 'score': 0.7032669}, {'id': 'https://openalex.org/keywords/hematology', 'display_name': 'Hematology', 'score': 0.41200954}], 'concepts': [{'id': 'https://openalex.org/C2776112149', 'wikidata': 'https://www.wikidata.org/wiki/Q7383611', 'display_name': 'Ruxolitinib', 'level': 4, 'score': 0.9742965}, {'id': 'https://openalex.org/C2778740236', 'wikidata': 'https://www.wikidata.org/wiki/Q933716', 'display_name': 'Polycythaemia', 'level': 2, 'score': 0.9120972}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.86745816}, {'id': 'https://openalex.org/C2779316324', 'wikidata': 'https://www.wikidata.org/wiki/Q212272', 'display_name': 'Hydroxycarbamide', 'level': 3, 'score': 0.83519864}, {'id': 'https://openalex.org/C2777357209', 'wikidata': 'https://www.wikidata.org/wiki/Q3595842', 'display_name': 'Phlebotomy', 'level': 2, 'score': 0.7032669}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.6554344}, {'id': 'https://openalex.org/C2780076729', 'wikidata': 'https://www.wikidata.org/wiki/Q1752571', 'display_name': 'Myelofibrosis', 'level': 3, 'score': 0.6132992}, {'id': 'https://openalex.org/C2778837598', 'wikidata': 'https://www.wikidata.org/wiki/Q948318', 'display_name': 'Polycythemia vera', 'level': 2, 'score': 0.56496567}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.49629647}, {'id': 'https://openalex.org/C194409129', 'wikidata': 'https://www.wikidata.org/wiki/Q103824', 'display_name': 'Hematology', 'level': 2, 'score': 0.41200954}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.33745873}, {'id': 'https://openalex.org/C2780007613', 'wikidata': 'https://www.wikidata.org/wiki/Q546523', 'display_name': 'Bone marrow', 'level': 2, 'score': 0.16776043}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.1004737}], 'mesh': [{'descriptor_ui': 'D000075242', 'descriptor_name': 'Janus Kinase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011087', 'descriptor_name': 'Polycythemia Vera', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000075242', 'descriptor_name': 'Janus Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000075242', 'descriptor_name': 'Janus Kinase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000075242', 'descriptor_name': 'Janus Kinase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011087', 'descriptor_name': 'Polycythemia Vera', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011087', 'descriptor_name': 'Polycythemia Vera', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D011087', 'descriptor_name': 'Polycythemia Vera', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D011087', 'descriptor_name': 'Polycythemia Vera', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30645821', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4221036323', 'https://openalex.org/W2887969332', 'https://openalex.org/W2757452091', 'https://openalex.org/W2616315621', 'https://openalex.org/W2592070663', 'https://openalex.org/W2562143728', 'https://openalex.org/W2272641588', 'https://openalex.org/W2064180006', 'https://openalex.org/W2059511422', 'https://openalex.org/W1985953548'], 'abstract_inverted_index': {'Patients': [0], 'with': [1, 40, 86, 276, 281], 'polycythaemia': [2, 87, 277], 'vera,': [3, 278], 'a': [4, 42, 108, 233, 271], 'myeloproliferative': [5], 'syndrome,': [6], 'are': [7, 48, 69, 178, 249], 'at': [8, 34], 'increased': [9], 'risk': [10, 234], 'of': [11, 100, 130, 149, 173, 218, 235, 262], 'thrombotic': [12], 'events.': [13], 'Marrow': [14], 'fibrosis': [15], 'and': [16, 32, 193, 205, 230], 'transformation': [17], 'to': [18, 144, 182, 212, 265], 'acute': [19], 'leukaemia': [20], 'can': [21], 'also': [22, 210], 'occur': [23], 'after': [24], 'several': [25], 'years.': [26], 'Treatment': [27], 'is': [28, 54, 59, 95, 105, 209, 222, 287], 'based': [29, 106], 'on': [30, 107, 258], 'phlebotomy': [31], 'aspirin': [33], 'low': [35], '(antiplatelet)': [36], 'doses,': [37], 'sometimes': [38], 'combined': [39], 'hydroxycarbamide,': [41], 'cytotoxic': [43], 'drug.': [44, 146], 'Various': [45], 'other': [46, 72, 152, 219, 282], 'drugs': [47, 283], 'available': [49, 250, 256], 'if': [50], 'hydroxycarbamide': [51, 91, 286], 'fails': [52], 'or': [53, 94, 140], 'poorly': [55, 96, 179], 'tolerated,': [56], 'but': [57], 'there': [58], 'no': [60, 247], 'consensus': [61], 'treatment.': [62], 'Ruxolitinib': [63, 76, 221, 239], 'inhibits': [64], 'Janus': [65], 'tyrosine': [66], 'kinases,': [67], 'which': [68], 'involved,': [70], 'among': [71], 'roles,': [73], 'in': [74, 80, 89, 102, 118, 128, 161, 166, 175, 243, 251], 'haematopoiesis.': [75], 'has': [77, 92], 'been': [78], 'authorised': [79], 'the': [81, 116, 134, 145, 150, 162, 167, 187, 214, 259], 'European': [82], 'Union': [83], 'for': [84, 122, 274], 'patients': [85, 120, 135, 275], 'vera': [88], 'whom': [90], 'failed': [93], 'tolerated.': [97], 'Clinical': [98], 'evaluation': [99], 'ruxolitinib': [101, 190, 263], 'this': [103, 176, 268], 'setting': [104], 'randomised,': [109], 'unblinded': [110], 'trial': [111], 'versus': [112], 'treatment': [113, 153], 'chosen': [114, 127], 'by': [115, 225], 'investigators,': [117], '222': [119], 'treated': [121], '32': [123], 'weeks.': [124], 'Hydroxycarbamide': [125], 'was': [126, 155, 158], '59%': [129], 'cases,': [131], 'even': [132], 'though': [133], 'had': [136], 'unacceptable': [137], 'adverse': [138, 171, 216], 'effects': [139, 172, 217], 'an': [141], 'inadequate': [142, 183], 'response': [143], 'The': [147, 170], 'efficacy': [148], "investigators'": [151], 'choices': [154], 'uncertain.': [156], 'Phlebotomy': [157], 'less': [159], 'frequent': [160], 'ruxofitinib': [163], 'group': [164], 'than': [165], 'control': [168], 'group.': [169], 'ruxotitinib': [174], 'situation': [177], 'documented,': [180], 'due': [181], 'long-term': [184], 'assessment.': [185], 'In': [186, 254], 'short': [188], 'term,': [189], 'causes': [191], 'anaemia': [192], 'thrombocytopenia,': [194], 'as': [195, 197, 279], 'well': [196], 'bleeding,': [198], 'potentially': [199], 'severe': [200], 'infections,': [201], 'headache,': [202], 'sensory': [203], 'disturbances,': [204], 'weight': [206], 'gain.': [207], 'It': [208], 'likely': [211], 'share': [213], 'serious': [215], 'immunosuppressants.': [220], 'mainly': [223], 'metabolised': [224], 'cytochrome': [226], 'P450': [227], 'isoenzymes': [228], 'CYP3A4': [229], 'CYP2C9,': [231], 'creating': [232], 'multiple': [236], 'drug': [237, 269], 'interactions.': [238], 'showed': [240], 'embryofetal': [241], 'toxicity': [242], 'animal': [244], 'studies.': [245], 'Virtually': [246], 'data': [248, 257], 'pregnant': [252], 'women.': [253], 'practice,': [255], 'harm-benefit': [260], 'balance': [261], 'fail': [264], 'show': [266], 'that': [267], 'represents': [270], 'tangible': [272], 'advance': [273], 'compared': [280], 'used': [284], 'when': [285], 'unsuitable.': [288]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4301456853', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-09T21:22:36.841736', 'created_date': '2022-10-05'}